Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
Front Pharmacol ; 12: 717065, 2021.
Artículo en Inglés | MEDLINE | ID: mdl-34366868

RESUMEN

Osteoporosis (OP) is a chronic bone disease characterized by aberrant microstructure and macrostructure of bone, leading to reduced bone mass and increased risk of fragile fractures. Anti-resorptive drugs, especially, bisphosphonates, are currently the treatment of choice in most developing countries. However, they do have limitations and adverse effects, which, to some extent, helped the development of anabolic drugs such as teriparatide and romosozumab. In patients with high or very high risk for fracture, sequential or combined therapies may be considered with the initial drugs being anabolic agents. Great endeavors have been made to find next generation drugs with maximal efficacy and minimal toxicity, and improved understanding of the role of different signaling pathways and their crosstalk in the pathogenesis of OP may help achieve this goal. Our review focused on recent progress with regards to the drug development by modification of Wnt pathway, while other pathways/molecules were also discussed briefly. In addition, new observations made in recent years in bone biology were summarized and discussed for the treatment of OP.

2.
Viruses ; 11(9)2019 08 23.
Artículo en Inglés | MEDLINE | ID: mdl-31450758

RESUMEN

Autophagy is a catabolic biological process in the body. By targeting exogenous microorganisms and aged intracellular proteins and organelles and sending them to the lysosome for phagocytosis and degradation, autophagy contributes to energy recycling. When cells are stimulated by exogenous pathogenic microorganisms such as viruses, activation or inhibition of autophagy is often triggered. As autophagy has antiviral effects, many viruses may escape and resist the process by encoding viral proteins. At the same time, viruses can also use autophagy to enhance their replication or increase the persistence of latent infections. Here, we give a brief overview of autophagy and DNA viruses and comprehensively review the known interactions between human and animal DNA viruses and autophagy and the role and mechanisms of autophagy in viral DNA replication and DNA virus-induced innate and acquired immunity.


Asunto(s)
Autofagia/fisiología , Virus ADN , Inmunidad Adaptativa , Adenoviridae/crecimiento & desarrollo , Adenoviridae/inmunología , Adenoviridae/metabolismo , Animales , Autofagosomas/metabolismo , Virus ADN/crecimiento & desarrollo , Virus ADN/inmunología , Virus ADN/metabolismo , Herpesviridae/crecimiento & desarrollo , Herpesviridae/inmunología , Herpesviridae/metabolismo , Interacciones Microbiota-Huesped , Humanos , Evasión Inmune , Inmunidad Innata , Lisosomas/metabolismo , Papillomaviridae/crecimiento & desarrollo , Papillomaviridae/inmunología , Papillomaviridae/metabolismo , Fagocitosis/fisiología , Transducción de Señal , Proteínas Virales/inmunología , Proteínas Virales/metabolismo , Replicación Viral/inmunología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA